SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-073364
Filing Date
2010-08-05
Accepted
2010-08-05 16:19:55
Documents
3
Period of Report
2010-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c04067e8vk.htm 8-K 9360
2 EXHIBIT 99.1 c04067exv99w1.htm EX-99.1 32600
3 GRAPHIC c04067p0406701.gif GRAPHIC 4617
  Complete submission text file 0000950123-10-073364.txt   50094
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 10994735
SIC: 2835 In Vitro & In Vivo Diagnostic Substances